Candriam Equities L Biotechnology C - Thesaurierung
LU0108459040
Candriam Equities L Biotechnology C - Thesaurierung/ LU0108459040 /
NAV 25.07.2024
Diff.+9,4500
Ertragstyp
Ausrichtung
Fondsgesellschaft
934,3600 USD
+1,02%
thesaurierend
Aktien
Candriam ▶
Zeitraum: 6 Monate 1 Jahr 2 Jahre 3 Jahre 5 Jahre
Anzahl an Fonds: 10 20 50
Titel
ISIN
Performance
Volatilität
Sharpe Ratio
1.
Janus Henderson Horizon Biotechnology Fund IU2 EUR
LU2441282626
+40,73%
20,14%
1,84
2.
Janus Henderson Horizon Biotechnology Fund A2 EUR
LU2441282899
+40,30%
20,44%
1,79
3.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) SGD
LU0320765992
+34,37%
18,10%
1,70
4.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP
LU0774687577
+34,18%
18,00%
1,70
5.
DWS ESG Biotech FC
DE000DWS2WY7
+33,18%
18,68%
1,58
6.
J.Henderson H.BioTech.F.IU2
LU1897414568
+38,33%
22,03%
1,57
7.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD
LU0195948822
+33,70%
19,17%
1,57
8.
DWS ESG Biotech TFC
DE000DWS2UA1
+32,99%
18,68%
1,57
9.
J.Henderson H.BioTech.F.H2
LU1897414485
+38,13%
22,03%
1,56
10.
F.Biotechnology Dis.Fd.W USD
LU0976566496
+33,57%
19,20%
1,56
...
43.
Candriam Equities L Biotechnology C - Thesaurierung
LU0108459040
+21,88%
16,73%
1,09